Basic Search  |  Summaries  |  Advanced SearchPenalty: £0
Year: 2020
Date: 9 July, 2020
Offence Group: competition-related offences
Offence Type: price-fixing or anti-competitive practices
Violation Description: Amilco admitted anti-competitive activity in settlement of a decision by the CMA that the company colluded with Aspen and Tiofarma to maintain Aspen's position as the sole supplier of the drug fludrocortisone in the UK, which increased in price up to 1800% during the agreement. All companies involved admitted to anti-competitive behaviour in a settlement. No fine was levied because the calculation of fines starts from a percentage of the worldwide turnover of the company in the last business year, which was zero.
Action Type: agency action
Settlement Type: Settlement with the CMA
Case Number: 50455
Agency: Competition and Markets Authority
Source of Data: (click here)